Kemvera, formerly known as New Iridium, announced progress in commercializing biochemicals. The Denver-based company has completed its process design for a 50,000-ton-per-year plant. This is a key milestone toward large-scale production.
To support this, Kemvera finalized the design for a 500-ton pre-commercial reactor. It also commissioned a 20-ton pilot reactor, demonstrating continuous operation. These steps move the company from research into real-world manufacturing. Kemvera uses domestic feedstocks like corn ethanol to make affordable, drop-in chemicals.
The company’s rebranding reflects its goal to develop bio-based solutions that help American farmers and strengthen U.S. manufacturing. Its proprietary platform converts domestically sourced feedstocks and CO₂ into sustainable chemicals. These alternatives to petroleum products support a circular economy.
The U.S. green chemicals market is expected to reach USD 7.46 billion by 2033. Kemvera works with ethanol producers and farmers to build a resilient, local supply chain. This connects Midwest farms to industrial users.
CEO Dr. Chern-Hooi Lim said, “These milestones bring us closer to delivering affordable chemicals from American-grown feedstocks. Rebranding to Kemvera shows our focus on growth and innovation.”
Looking ahead, Kemvera plans to use its products, like bio-acetic acid and bio-ethyl acetate, in footwear, disinfectants, and other consumer goods. The company is raising Series A funding and seeking partners to expand its reach. Its goal is to boost U.S. leadership in sustainable chemicals while supporting rural economies.
